Efficacy and tolerability of folfirinox in treatment of advanced pancreatic cancer patients /
فعالية و قابلية تحمل علاج فولفيرينوكس فى علاج حالات أورام البنكرياس المتقدم و المنتشر
Haider Yousif Hameed Shukur ; Supervised Ehsan Gamal Eldin Elghonemy , Hanan Selim Mosalem , Amr Yehia Sakr
- Cairo : Haider Yousif Hameed Shukur , 2013
- 149 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical
In compares of FOLFIRINOX to Gemciabine group according to treatment line, we find that the ORR to FOLFIRINOX was 45% versus 10% in Gemcitabine arm also overall survival was 11 months versus 7 months although the toxicity of this protocol was greater than Gemcitabine, but all was manageable and tolerable